Responses
Clinical/translational cancer immunotherapy
Original research
Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models
Compose a Response to This Article
Other responses
No responses have been published for this article.
